# 4D Molecular (FDMT) — Earnings

FDMT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/fdmt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$1.01 |
| EPS estimate | −$0.98 |
| EPS surprise | −2.79% |
| Revenue surprise | −68.73% |
| Revenue | $90,000.00 |
| Revenue estimate | $287,857.00 |
| Reported | Nov 10, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1650648/000119312525273343/fdmt-20250930.htm) |

4D Molecular's most recent quarter in the table is Q3 2025, reported November 10, 2025. It posted a loss of $1.01 per share, slightly wider than the $0.98 loss expected, a 2.79% miss. Revenue was $90,000 against a $287,857 estimate. A year earlier, in Q3 2024, the loss was $0.79 per share on revenue of $3,000. The nine-month loss was $2.85 per share, against $2.08 a year earlier.

Every one of the 18 quarters in the table was a loss. Annual losses were $2.48 per share in 2021, $3.32 in 2022 and $2.97 in 2024; the table has no Q4 2023 row. Revenue has been small and uneven. The largest amounts were $20.2 million in Q3 2023 and $14.6 million in Q2 2021, and those were also the two smallest losses, at $0.24 and $0.28 per share. Q3 2025 was the widest loss in the table. Against estimates there were 9 beats, 8 misses and one match.

In past years the Q4 report came between late February and late March. The table does not yet show a quarter newer than Q3 2025. The next update will show whether losses keep widening.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 10, 2025 | −$0.98 | −$1.01 | -2.79% | $287,857.00 | $90,000.00 |
| Q2 2025 | Aug 11, 2025 | −$0.73 | −$0.98 | -34.74% | $390,525.00 | $15,000.00 |
| Q1 2025 | May 8, 2025 | −$0.87 | −$0.86 | 1.24% | $455,314.00 | $14,000.00 |
| Q4 2024 | Feb 28, 2025 | −$0.84 | −$0.89 | -6.52% | $1.4M | $500.00 |
| Q3 2024 | Nov 13, 2024 | −$0.68 | −$0.79 | -16.88% | $1.6M | $3,000.00 |
| Q2 2024 | Aug 8, 2024 | −$0.68 | −$0.63 | 7.92% | $1.3M | $5,000.00 |
| Q1 2024 | May 9, 2024 | −$0.74 | −$0.66 | 10.92% | $1.4M | — |
| Q3 2023 | Nov 9, 2023 | −$0.61 | −$0.24 | 60.87% | $8.1M | $20.2M |
| Q2 2023 | Aug 9, 2023 | −$0.78 | −$0.77 | 1.76% | $848,333.00 | $239,000.00 |
| Q1 2023 | May 11, 2023 | −$0.89 | −$0.88 | 1.49% | $1.3M | $298,000.00 |
| Q4 2022 | Mar 15, 2023 | −$0.79 | −$0.84 | -6.91% | $873,400.00 | $1.2M |
| Q3 2022 | Nov 8, 2022 | −$0.84 | −$0.79 | 6.40% | $376,250.00 | $500,000.00 |
| Q2 2022 | Aug 11, 2022 | −$0.85 | −$0.87 | -2.84% | $856,000.00 | $162,000.00 |
| Q1 2022 | May 12, 2022 | −$0.81 | −$0.82 | -0.92% | $758,333.00 | $1.2M |
| Q4 2021 | Mar 28, 2022 | −$0.85 | −$0.85 | 0.00% | $900,000.00 | $96,000.00 |
| Q3 2021 | Nov 10, 2021 | −$0.81 | −$0.82 | -1.23% | $175,000.00 | $1.4M |
| Q2 2021 | Aug 12, 2021 | −$0.68 | −$0.28 | 58.82% | $587,500.00 | $14.6M |
| Q1 2021 | May 13, 2021 | −$0.83 | −$0.53 | 36.14% | $562,500.00 | $2.0M |

## Frequently Asked Questions

### When did 4D Molecular (FDMT) last report earnings?

4D Molecular last reported on Nov 10, 2025, covering fiscal Q3 2025.

### Did FDMT beat earnings estimates?

No. 4D Molecular reported EPS of −$1.01 for Q3 2025 against a −$0.98 estimate — a 2.79% miss.

### How much revenue did FDMT report last quarter?

4D Molecular reported $90,000.00 in revenue for Q3 2025, against a consensus estimate of $287,857.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).